Dupilumab Induced Hair Regrowth in Alopecia Totalis.
J Drugs Dermatol
; 22(4): 410-412, 2023 Apr 01.
Article
en En
| MEDLINE
| ID: mdl-37026876
ABSTRACT
Alopecia Areata (AA) is an autoimmune process that results in varying degrees of hair loss. Currently, there is no single treatment that has proven to be efficacious in a large cohort of patients. Dupilumab, a human monoclonal antibody recently approved for the treatment of atopic dermatitis, may be a potential treatment option for patients with treatment resistant AA. J Drugs Dermatol. 2023;22(4) doi10.36849/JDD.6254 Citation Bur D, Kim K, Rogge M. Dupilumab induced hair regrowth in alopecia totalis. J Drugs Dermatol. 2023;22(4)410-412. doi10.36849/JDD.6254.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Alopecia Areata
Idioma:
En
Revista:
J Drugs Dermatol
Asunto de la revista:
DERMATOLOGIA
Año:
2023
Tipo del documento:
Article